EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment.
Shiiya A, Noguchi T, Tomaru U, Ariga S, Takashima Y, Ohhara Y, Taguchi J, Takeuchi S, Shimizu Y, Kinoshita I, Koizumi T, Matsuno Y, Shinagawa N, Sakakibara-Konishi J, Dosaka-Akita H.
Shiiya A, et al. Among authors: noguchi t.
Cancer Sci. 2023 Apr;114(4):1270-1283. doi: 10.1111/cas.15701. Epub 2022 Dec 26.
Cancer Sci. 2023.
PMID: 36529523
Free PMC article.